Literature DB >> 3013774

Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats.

T Okamura, M Miyazaki, T Inagami, N Toda.   

Abstract

The possible role of the renin-angiotensin system in the maintenance of hypertension in two-kidney, one clip hypertensive rats was studied. Plasma renin activity rose rapidly and markedly in association with the elevation of blood pressure and then decreased gradually, although blood pressure remained high. Renin activity in the lung, aorta, and mesenteric artery also increased with the development of hypertension and then decreased in a way similar to that of plasma renin activity at the chronic stage of hypertension. Plasma angiotensin converting enzyme activity did not change significantly until 16 weeks after unilateral renal artery clipping, whereas vascular angiotensin converting enzyme activity significantly increased at the chronic, but not the acute, stage of hypertension. In chronically renal hypertensive rats, 1-sarcosine, 8-isoleucine angiotensin II or enalapril, an angiotensin converting enzyme inhibitor, lowered the blood pressure and enalapril also lowered the angiotensin converting enzyme activity of vascular tissues. The constrictor effect of angiotensin I was greater in isolated arteries from chronically hypertensive rats than in those from age-matched normotensive rats. These results suggest that the vascular renin-angiotensin system plays an important role in the maintenance of two-kidney, one clip hypertension. Elevated vascular angiotensin converting enzyme activity appears to increase local production of angiotensin II, which results in vasoconstriction by acting directly and indirectly through adrenergic nerves on vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013774     DOI: 10.1161/01.hyp.8.7.560

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  24 in total

1.  New developments in renin and hypertension.

Authors:  N J Samani
Journal:  BMJ       Date:  1991-04-27

2.  Gradual reactivation of vascular angiotensin I to angiotensin II conversion during chronic ACE inhibitor therapy in patients with diabetes mellitus.

Authors:  D C Sharman; A D Morris; A D Struthers
Journal:  Diabetologia       Date:  2007-08-04       Impact factor: 10.122

Review 3.  Newer ACE inhibitors. A look at the future.

Authors:  A Salvetti
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

Review 4.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

Review 5.  Mechanism of action of angiotensin-converting enzyme (ACE) inhibitors in hypertension and heart failure. Role of plasma versus tissue ACE.

Authors:  V J Dzau
Journal:  Drugs       Date:  1990       Impact factor: 9.546

6.  The vascular renin-angiotensin system contributes to blunted vasodilation induced by transient high pressure in human adipose microvessels.

Authors:  Matthew J Durand; Shane A Phillips; Michael E Widlansky; Mary F Otterson; David D Gutterman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-01       Impact factor: 4.733

Review 7.  Renal effects of antihypertensive drugs.

Authors:  W A Schlueter; D C Batlle
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

8.  Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme.

Authors:  R Morishita; G H Gibbons; K E Ellison; W Lee; L Zhang; H Yu; Y Kaneda; T Ogihara; V J Dzau
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

9.  Novel and effective gene transfer technique for study of vascular renin angiotensin system.

Authors:  R Morishita; G H Gibbons; Y Kaneda; T Ogihara; V J Dzau
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  Enhanced cardiac angiotensinogen gene expression and angiotensin converting enzyme activity in tachypacing-induced heart failure in rats.

Authors:  M Finckh; W Hellmann; D Ganten; A Furtwängler; J Allgeier; M Boltz; J Holtz
Journal:  Basic Res Cardiol       Date:  1991 Jul-Aug       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.